Cargando…
Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
Acanthamoeba species, Naegleria fowleri, and Balamuthia mandrillaris are opportunistic pathogens that cause a range of brain, skin, eye, and disseminated diseases in humans and animals. These pathogenic free-living amoebae (pFLA) are commonly misdiagnosed and have sub-optimal treatment regimens whic...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206040/ https://www.ncbi.nlm.nih.gov/pubmed/37234530 http://dx.doi.org/10.3389/fmicb.2023.1149145 |
_version_ | 1785046141078863872 |
---|---|
author | Ferrins, Lori Buskes, Melissa J. Kapteyn, Madison M. Engels, Hannah N. Enos, Suzanne E. Lu, Chenyang Klug, Dana M. Singh, Baljinder Quotadamo, Antonio Bachovchin, Kelly Tear, Westley F. Spaulding, Andrew E. Forbes, Katherine C. Bag, Seema Rivers, Mitch LeBlanc, Catherine Burchfield, Erin Armand, Jeremy R. Diaz-Gonzalez, Rosario Ceballos-Perez, Gloria García-Hernández, Raquel Pérez-Moreno, Guiomar Bosch-Navarrete, Cristina Gómez-Liñán, Claudia Ruiz-Pérez, Luis Miguel Gamarro, Francisco González-Pacanowska, Dolores Navarro, Miguel Mensa-Wilmot, Kojo Pollastri, Michael P. Kyle, Dennis E. Rice, Christopher A. |
author_facet | Ferrins, Lori Buskes, Melissa J. Kapteyn, Madison M. Engels, Hannah N. Enos, Suzanne E. Lu, Chenyang Klug, Dana M. Singh, Baljinder Quotadamo, Antonio Bachovchin, Kelly Tear, Westley F. Spaulding, Andrew E. Forbes, Katherine C. Bag, Seema Rivers, Mitch LeBlanc, Catherine Burchfield, Erin Armand, Jeremy R. Diaz-Gonzalez, Rosario Ceballos-Perez, Gloria García-Hernández, Raquel Pérez-Moreno, Guiomar Bosch-Navarrete, Cristina Gómez-Liñán, Claudia Ruiz-Pérez, Luis Miguel Gamarro, Francisco González-Pacanowska, Dolores Navarro, Miguel Mensa-Wilmot, Kojo Pollastri, Michael P. Kyle, Dennis E. Rice, Christopher A. |
author_sort | Ferrins, Lori |
collection | PubMed |
description | Acanthamoeba species, Naegleria fowleri, and Balamuthia mandrillaris are opportunistic pathogens that cause a range of brain, skin, eye, and disseminated diseases in humans and animals. These pathogenic free-living amoebae (pFLA) are commonly misdiagnosed and have sub-optimal treatment regimens which contribute to the extremely high mortality rates (>90%) when they infect the central nervous system. To address the unmet medical need for effective therapeutics, we screened kinase inhibitor chemotypes against three pFLA using phenotypic drug assays involving CellTiter-Glo 2.0. Herein, we report the activity of the compounds against the trophozoite stage of each of the three amoebae, ranging from nanomolar to low micromolar potency. The most potent compounds that were identified from this screening effort were: 2d (A. castellanii EC(50): 0.92 ± 0.3 μM; and N. fowleri EC(50): 0.43 ± 0.13 μM), 1c and 2b (N. fowleri EC(50)s: <0.63 μM, and 0.3 ± 0.21 μM), and 4b and 7b (B. mandrillaris EC(50)s: 1.0 ± 0.12 μM, and 1.4 ± 0.17 μM, respectively). With several of these pharmacophores already possessing blood–brain barrier (BBB) permeability properties, or are predicted to penetrate the BBB, these hits present novel starting points for optimization as future treatments for pFLA-caused diseases. |
format | Online Article Text |
id | pubmed-10206040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102060402023-05-25 Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes Ferrins, Lori Buskes, Melissa J. Kapteyn, Madison M. Engels, Hannah N. Enos, Suzanne E. Lu, Chenyang Klug, Dana M. Singh, Baljinder Quotadamo, Antonio Bachovchin, Kelly Tear, Westley F. Spaulding, Andrew E. Forbes, Katherine C. Bag, Seema Rivers, Mitch LeBlanc, Catherine Burchfield, Erin Armand, Jeremy R. Diaz-Gonzalez, Rosario Ceballos-Perez, Gloria García-Hernández, Raquel Pérez-Moreno, Guiomar Bosch-Navarrete, Cristina Gómez-Liñán, Claudia Ruiz-Pérez, Luis Miguel Gamarro, Francisco González-Pacanowska, Dolores Navarro, Miguel Mensa-Wilmot, Kojo Pollastri, Michael P. Kyle, Dennis E. Rice, Christopher A. Front Microbiol Microbiology Acanthamoeba species, Naegleria fowleri, and Balamuthia mandrillaris are opportunistic pathogens that cause a range of brain, skin, eye, and disseminated diseases in humans and animals. These pathogenic free-living amoebae (pFLA) are commonly misdiagnosed and have sub-optimal treatment regimens which contribute to the extremely high mortality rates (>90%) when they infect the central nervous system. To address the unmet medical need for effective therapeutics, we screened kinase inhibitor chemotypes against three pFLA using phenotypic drug assays involving CellTiter-Glo 2.0. Herein, we report the activity of the compounds against the trophozoite stage of each of the three amoebae, ranging from nanomolar to low micromolar potency. The most potent compounds that were identified from this screening effort were: 2d (A. castellanii EC(50): 0.92 ± 0.3 μM; and N. fowleri EC(50): 0.43 ± 0.13 μM), 1c and 2b (N. fowleri EC(50)s: <0.63 μM, and 0.3 ± 0.21 μM), and 4b and 7b (B. mandrillaris EC(50)s: 1.0 ± 0.12 μM, and 1.4 ± 0.17 μM, respectively). With several of these pharmacophores already possessing blood–brain barrier (BBB) permeability properties, or are predicted to penetrate the BBB, these hits present novel starting points for optimization as future treatments for pFLA-caused diseases. Frontiers Media S.A. 2023-05-10 /pmc/articles/PMC10206040/ /pubmed/37234530 http://dx.doi.org/10.3389/fmicb.2023.1149145 Text en Copyright © 2023 Ferrins, Buskes, Kapteyn, Engels, Enos, Lu, Klug, Singh, Quotadamo, Bachovchin, Tear, Spaulding, Forbes, Bag, Rivers, LeBlanc, Burchfield, Armand, Diaz-Gonzalez, Ceballos-Perez, García-Hernández, Pérez-Moreno, Bosch-Navarrete, Gómez-Liñán, Ruiz-Pérez, Gamarro, González-Pacanowska, Navarro, Mensa-Wilmot, Pollastri, Kyle and Rice. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Ferrins, Lori Buskes, Melissa J. Kapteyn, Madison M. Engels, Hannah N. Enos, Suzanne E. Lu, Chenyang Klug, Dana M. Singh, Baljinder Quotadamo, Antonio Bachovchin, Kelly Tear, Westley F. Spaulding, Andrew E. Forbes, Katherine C. Bag, Seema Rivers, Mitch LeBlanc, Catherine Burchfield, Erin Armand, Jeremy R. Diaz-Gonzalez, Rosario Ceballos-Perez, Gloria García-Hernández, Raquel Pérez-Moreno, Guiomar Bosch-Navarrete, Cristina Gómez-Liñán, Claudia Ruiz-Pérez, Luis Miguel Gamarro, Francisco González-Pacanowska, Dolores Navarro, Miguel Mensa-Wilmot, Kojo Pollastri, Michael P. Kyle, Dennis E. Rice, Christopher A. Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title | Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title_full | Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title_fullStr | Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title_full_unstemmed | Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title_short | Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
title_sort | identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206040/ https://www.ncbi.nlm.nih.gov/pubmed/37234530 http://dx.doi.org/10.3389/fmicb.2023.1149145 |
work_keys_str_mv | AT ferrinslori identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT buskesmelissaj identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT kapteynmadisonm identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT engelshannahn identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT enossuzannee identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT luchenyang identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT klugdanam identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT singhbaljinder identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT quotadamoantonio identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT bachovchinkelly identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT tearwestleyf identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT spauldingandrewe identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT forbeskatherinec identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT bagseema identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT riversmitch identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT leblanccatherine identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT burchfielderin identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT armandjeremyr identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT diazgonzalezrosario identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT ceballosperezgloria identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT garciahernandezraquel identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT perezmorenoguiomar identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT boschnavarretecristina identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT gomezlinanclaudia identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT ruizperezluismiguel identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT gamarrofrancisco identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT gonzalezpacanowskadolores identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT navarromiguel identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT mensawilmotkojo identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT pollastrimichaelp identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT kyledennise identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes AT ricechristophera identificationofnovelantiamoebicpharmacophoresfromkinaseinhibitorchemotypes |